Traditional corticosteroids for induction of remission in Crohn's disease
about
Anti-IL-17 monoclonal antibody for induction of remission in Crohn's diseaseHelminth therapy (worms) for induction of remission in inflammatory bowel diseaseHelminths for induction of remission in inflammatory bowel diseaseSargramostim (GM-CSF) for induction of remission in Crohn's diseaseSargramostim (GM-CSF) for induction of remission in Crohn's diseasePharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsInterventions and targets aimed at improving quality in inflammatory bowel disease ambulatory careEvidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanCurrent therapy of pediatric Crohn's diseaseManagement of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.Management of active Crohn disease.Role of conventional therapies in the era of biological treatment in Crohn's disease.Managing refractory Crohn's disease: challenges and solutionsEarly postoperative complications in patients with Crohn's disease given and not given preoperative total parenteral nutrition.Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.MC-12, an annexin A1-based peptide, is effective in the treatment of experimental colitisClinical outcomes and predictive factors for response after the first course of corticosteroid therapy in patients with Crohn's diseaseThe impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?Care of inflammatory bowel disease patients in remission.Second Korean guidelines for the management of Crohn's disease.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challengesEvidence-based clinical practice guidelines for inflammatory bowel disease.Up-regulation of IGF Binding Protein-3 Inhibits Colonic Inflammatory Response.
P2860
Q24200202-7803DF81-A5B2-4FC2-98F6-C3CA70FBC1B0Q24201067-DADB3233-B25F-4EB6-848C-DDD673478A18Q24234013-A85FA59C-F8B6-42BB-8FCD-5E34EA0DF6A5Q24235068-4F0D3C3D-3D13-474E-B57F-A6489525B7FBQ24235115-A3D90AB8-3BCF-4711-976B-5F334912DE3DQ26768280-D906C44A-C65A-4886-B01E-D1B76C97BBC7Q26823569-6D1F723B-EAF2-43B1-B540-4DBFACCA553DQ26829392-DC1CA063-0651-4ACD-9555-0E0636A44FDEQ28081919-FA4D0BC5-96EE-4562-B9BF-8F3DC7F144F4Q33819478-A6CB58F1-9A1A-4846-918F-DEC6D9C16781Q34137254-A9A31206-71EC-4A82-B7C6-3E6EE943C6E9Q34345967-8EACFA60-571C-4686-B123-AE5E9BC76571Q34831072-0F261B81-48BC-44D1-B1D3-0B64A4AEE068Q35460367-9789B510-75DA-44A5-9EA6-1C1A7240D5FCQ35755946-6EC1BA19-69CE-4A0A-912D-F2BCC63F6F17Q36043446-DBFEF5E7-74F9-4D1F-82F0-FFE9474EFC22Q36109503-08E04DB6-ED35-42E3-AF56-16803F4FC6E2Q36609559-B88CE40F-7DDE-4CD4-80F8-B66D18EE1DF5Q37277894-1AFE2B11-71D0-473E-BF83-F835865EFF63Q37540172-04CDADD9-E07A-4576-AB25-E76F9B47B741Q37662498-7A9CBC74-3A8E-46A0-9003-4195AD13AF6DQ38394726-30154F72-697B-4E3C-A718-11321FFC8F51Q42375646-574F218F-B201-4D35-943E-B13468A95587Q50079201-2E012243-5D3B-4720-AB29-DBD948697455Q55386298-4D42473F-2B00-49F0-AF39-B312D7B90586
P2860
Traditional corticosteroids for induction of remission in Crohn's disease
description
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2008/04/23)
@fr
articolo scientifico (pubblicato il 2008/04/23)
@it
artigo científico (publicado na 2008/04/23)
@pt
artikull shkencor
@sq
artículu científicu espublizáu en 2008
@ast
scientific article (published 2008-04-23)
@en
vedecký článok (publikovaný 2008/04/23)
@sk
videnskabelig artikel (udgivet 2008/04/23)
@da
name
Traditional corticosteroids for induction of remission in Crohn's disease
@ast
Traditional corticosteroids for induction of remission in Crohn's disease
@en
Traditional corticosteroids for induction of remission in Crohn's disease
@en-gb
Traditional corticosteroids for induction of remission in Crohn's disease
@nl
type
label
Traditional corticosteroids for induction of remission in Crohn's disease
@ast
Traditional corticosteroids for induction of remission in Crohn's disease
@en
Traditional corticosteroids for induction of remission in Crohn's disease
@en-gb
Traditional corticosteroids for induction of remission in Crohn's disease
@nl
prefLabel
Traditional corticosteroids for induction of remission in Crohn's disease
@ast
Traditional corticosteroids for induction of remission in Crohn's disease
@en
Traditional corticosteroids for induction of remission in Crohn's disease
@en-gb
Traditional corticosteroids for induction of remission in Crohn's disease
@nl
P2093
P2860
P3181
P1476
Traditional corticosteroids for induction of remission in Crohn's disease
@en
P2093
A H Steinhart
A M Griffiths
P2860
P304
P3181
P356
10.1002/14651858.CD006792.PUB2
P577
2008-04-16T00:00:00Z